The motion of trees in the wind: a data synthesis

Interactions between wind and trees control energy exchanges between the atmosphere and forest canopies. This energy exchange can lead to the widespread damage of trees, and wind is a key disturbance agent in many of the world\u27s forests. However, most research on this topic has focused on conifer plantations, where risk management is economically important, rather than broadleaf forests, which dominate the forest carbon cycle. This study brings together tree motion time-series data to systematically evaluate the factors influencing tree responses to wind loading, including data from both broadleaf and coniferous trees in forests and open environments. We found that the two most descriptive features of tree motion were (a) the fundamental frequency, which is a measure of the speed at which a tree sways and is strongly related to tree height, and (b) the slope of the power spectrum, which is related to the efficiency of energy transfer from wind to trees. Intriguingly, the slope of the power spectrum was found to remain constant from medium to high wind speeds for all trees in this study. This suggests that, contrary to some predictions, damping or amplification mechanisms do not change dramatically at high wind speeds, and therefore wind damage risk is related, relatively simply, to wind speed. Conifers from forests were distinct from broadleaves in terms of their response to wind loading. Specifically, the fundamental frequency of forest conifers was related to their size according to the cantilever beam model (i.e. vertically distributed mass), whereas broadleaves were better approximated by the simple pendulum model (i.e. dominated by the crown). Forest conifers also had a steeper slope of the power spectrum. We interpret these finding as being strongly related to tree architecture; i.e. conifers generally have a simple shape due to their apical dominance, whereas broadleaves exhibit a much wider range of architectures with more dominant crowns

Towards a macroscope : leveraging technology to transform the breadth, scale and resolution of macroecological data

M.D. is grateful for support from the Templeton Foundation (grant #60501, “Putting the Extended Evolutionary Synthesis to the Test”) and from a Leverhulme Trust Fellowship.The problem Earth‐based observations of the biosphere are spatially biased in ways that can limit our ability to detect macroecological patterns and changes in biodiversity. To resolve this problem, we need to supplement the ad hoc data currently collected with planned biodiversity monitoring, in order to approximate global stratified random sampling of the planet. We call this all‐encompassing observational system ‘the macroscope’. The solution With a focus on the marine realm, we identify seven main biosphere observation tools that compose the macroscope: satellites, drones, camera traps, passive acoustic samplers, biologgers, environmental DNA and human observations. By deploying a nested array of these tools that fills current gaps in monitoring, we can achieve a macroscope fit for purpose and turn these existing powerful tools into more than the sum of their parts. An appeal Building a macroscope requires commitment from many fields, together with coordinated actions to attract the level of funding required for such a venture. We call on macroecologists to become advocates for the macroscope and to engage with existing global observation networks.PostprintPeer reviewe

Phenotype and genotype of concurrent keratoconus and Fuchs endothelial corneal dystrophy

PURPOSE: To characterise the phenotype and genotype of concurrent keratoconus and Fuchs endothelial corneal dystrophy (KC + FECD). METHODS: We recruited 20 patients with concurrent KC + FECD for a retrospective observational case series from the United Kingdom and the Czech Republic. We compared eight parameters of corneal shape (Pentacam, Oculus) with two groups of age-matched controls who had either isolated keratoconus (KC) or isolated FECD. We genotyped probands for an intronic triplet TCF4 repeat expansion (CTG18.1) and the ZEB1 variant c.1920G >T p.(Gln640His). RESULTS: The median age at diagnosis of patients with KC + FECD was 54 (interquartile range 46 to 66) years, with no evidence of KC progression (median follow-up 84 months, range 12 to 120 months). The mean (standard deviation (SD)) of the minimum corneal thickness, 493 (62.7) μm, was greater than eyes with KC, 458 (51.1) μm, but less than eyes with FECD, 590 (55.6) μm. Seven other parameters of corneal shape were more like KC than FECD. Seven (35%) probands with KC + FECD had a TCF4 repeat expansion of ≥50 compared to five controls with isolated FECD. The average of the largest TCF4 expansion in cases with KC + FECD (46 repeats, SD 36 repeats) was similar to the age-matched controls with isolated FECD (36 repeats, SD 28 repeats; p = 0.299). No patient with KC + FECD harboured the ZEB1 variant. CONCLUSIONS: The KC + FECD phenotype is consistent with KC but with superimposed stromal swelling from endothelial disease. The proportion of cases with a TCF4 expansion is similar in concurrent KC + FECD and age-matched controls with isolated FECD

The motion of trees in the wind : a data synthesis

Interactions between wind and trees control energy exchanges between the atmosphere and forest canopies. This energy exchange can lead to the widespread damage of trees, and wind is a key disturbance agent in many of the world’s forests. However, most research on this topic has focused on conifer plantations, where risk management is economically important, rather than broadleaf forests, which dominate the forest carbon cycle. This study brings together tree motion time-series data to systematically evaluate the factors influencing tree responses to wind loading, including data from both broadleaf and coniferous trees in forests and open environments. Wefoundthatthetwomostdescriptive features of tree motion were (a) the fundamental frequency, which is a measure of the speed at which a tree sways and is strongly related to tree height, and (b) the slope of the power spectrum, which is related to the efficiency of energy transfer from wind to trees. Intriguingly, the slope of the power spectrum was found to remain constant from medium to high wind speeds for all trees in this study. This suggests that, contrary to some predictions, damping or amplification mechanisms do not change dramatically at high wind speeds, and therefore wind damage risk is related, relatively simply, to wind speed. Conifers from forests were distinct from broadleaves in terms of their response to wind loading. Specifically, the fundamental frequency of forest conifers was related to their size according to the cantilever beam model (i.e. vertically distributed mass), whereas broadleaves were better approximated by the simple pendulum model (i.e. dominated by the crown). Forest conifers also had a steeper slope of the power spectrum. We interpret these finding as being strongly related to tree architecture; i.e. conifers generally have a simple shape due to their apical dominance, whereas broadleaves exhibit a much wider range of architectures with more dominant crowns

Photodegradation of Selected PCBs in the Presence of Nano-TiO2 as Catalyst and H2O2 as an Oxidant

Photodegradation of five strategically selected PCBs was carried out in acetonitrile/water 80:20. Quantum chemical calculations reveal that PCBs without any chlorine on ortho-positions are closer to be planar, while PCBs with at least one chlorine atoms at the ortho-positions causes the two benzene rings to be nearly perpendicular. Light-induced degradation of planar PCBs is much slower than the perpendicular ones. The use of nano-TiO2 speeds up the degradation of the planar PCBs, but slows down the degradation of the non-planar ones. The use of H2O2 speeds up the degradation of planar PCBs greatly (by >20 times), but has little effect on non-planar ones except 2,3,5,6-TCB. The relative photodegradation rate is: 2,2′,4,4′-TCB > 2,3,5,6-TCB > 2,6-DCB ≈ 3,3′,4,4′-TCB > 3,4′,5-TCB. The use of H2O2 in combination with sunlight irradiation could be an efficient and “green” technology for PCB remediation

Health, education, and social care provision after diagnosis of childhood visual disability

Aim: To investigate the health, education, and social care provision for children newly diagnosed with visual disability.Method: This was a national prospective study, the British Childhood Visual Impairment and Blindness Study 2 (BCVIS2), ascertaining new diagnoses of visual impairment or severe visual impairment and blindness (SVIBL), or equivalent vi-sion. Data collection was performed by managing clinicians up to 1-year follow-up, and included health and developmental needs, and health, education, and social care provision.Results: BCVIS2 identified 784 children newly diagnosed with visual impairment/SVIBL (313 with visual impairment, 471 with SVIBL). Most children had associated systemic disorders (559 [71%], 167 [54%] with visual impairment, and 392 [84%] with SVIBL). Care from multidisciplinary teams was provided for 549 children (70%). Two-thirds (515) had not received an Education, Health, and Care Plan (EHCP). Fewer children with visual impairment had seen a specialist teacher (SVIBL 35%, visual impairment 28%, χ2p < 0.001), or had an EHCP (11% vs 7%, χ2p < 0 . 01).Interpretation: Families need additional support from managing clinicians to access recommended complex interventions such as the use of multidisciplinary teams and educational support. This need is pressing, as the population of children with visual impairment/SVIBL is expected to grow in size and complexity.This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Background Trials of fluoxetine for recovery after stroke report conflicting results. The Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral fluoxetine for 6 months after stroke improves functional outcome in an ethnically diverse population. Methods AFFINITY was a randomised, parallel-group, double-blind, placebo-controlled trial done in 43 hospital stroke units in Australia (n=29), New Zealand (four), and Vietnam (ten). Eligible patients were adults (aged ≥18 years) with a clinical diagnosis of acute stroke in the previous 2–15 days, brain imaging consistent with ischaemic or haemorrhagic stroke, and a persisting neurological deficit that produced a modified Rankin Scale (mRS) score of 1 or more. Patients were randomly assigned 1:1 via a web-based system using a minimisation algorithm to once daily, oral fluoxetine 20 mg capsules or matching placebo for 6 months. Patients, carers, investigators, and outcome assessors were masked to the treatment allocation. The primary outcome was functional status, measured by the mRS, at 6 months. The primary analysis was an ordinal logistic regression of the mRS at 6 months, adjusted for minimisation variables. Primary and safety analyses were done according to the patient's treatment allocation. The trial is registered with the Australian New Zealand Clinical Trials Registry, ACTRN12611000774921. Findings Between Jan 11, 2013, and June 30, 2019, 1280 patients were recruited in Australia (n=532), New Zealand (n=42), and Vietnam (n=706), of whom 642 were randomly assigned to fluoxetine and 638 were randomly assigned to placebo. Mean duration of trial treatment was 167 days (SD 48·1). At 6 months, mRS data were available in 624 (97%) patients in the fluoxetine group and 632 (99%) in the placebo group. The distribution of mRS categories was similar in the fluoxetine and placebo groups (adjusted common odds ratio 0·94, 95% CI 0·76–1·15; p=0·53). Compared with patients in the placebo group, patients in the fluoxetine group had more falls (20 [3%] vs seven [1%]; p=0·018), bone fractures (19 [3%] vs six [1%]; p=0·014), and epileptic seizures (ten [2%] vs two [<1%]; p=0·038) at 6 months. Interpretation Oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and epileptic seizures. These results do not support the use of fluoxetine to improve functional outcome after stroke